Affording expensive new drugs

Often lost in the indignant protests over the NHS not funding the latest ‘wonder drug’ is that such drugs can be eyewateringly expensive. The latest furore has been over NICE’s provisional determination on Kadcyla (trastuzumab emtansine) – the view from NICE was that this drug is not cost-effective unless the drug company reduces the price, which they have so far declined to do.

Affording expensive new drugs

Add yours ↓
Web design and marketing agency Leamington Spa